Sotera Health's projection of its adjusted EPS for FY24 being significantly lower than the estimated $0.87 suggests that the company might be facing operational or market challenges that could negatively impact its financial performance. This news is likely to concern investors and could lead to a decrease in the stock price in the short term as market participants adjust their expectations based on this new information.